Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes

ElsevierVolume 51, Issue 5, September 2025, 101679Diabetes & MetabolismAuthor links open overlay panel, , , , , , Section snippetsCRediT authorship contribution statement

Bruno Guerci: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. Michael Joubert: Formal analysis, Funding acquisition, Investigation, Validation, Writing – review & editing. Ghassan Riachi: Writing – review & editing. Marie-Lauren Antoine: Project administration, Writing – review & editing, Methodology, Supervision. Delphine Clabaut:

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We sincerely thank the Eli Lilly team for their support in the context of this Investigator-initiated Trial (IIT), particularly the Drs Myriam Rosilio, Anne Dib, and Lisa Ludwig.

References (7)

There are more references available in the full text version of this article.

View full text

© 2025 Published by Elsevier Masson SAS.

Comments (0)

No login
gif